ArticleAntonie van Leeuwenhoek2026
Whole genome analysis reveals chromosomal and plasmid-mediated convergence of drug resistance in Klebsiella pneumoniae isolates.
Article in Antonie van Leeuwenhoek, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The emergence of antimicrobial resistance (AMR) in Klebsiella pneumoniae poses a significant threat to public health. This study aims to elucidate the mechanisms of colistin and fluoroquinolone resistance using whole-genome sequencing in two K. pneumoniae isolates. Two clinical isolates of K. pneumoniae that phenotypically showed resistance to colistin and ciprofloxacin but did not yield any corresponding drug resistance genes were selected from a tertiary care facility in Chennai, India. Genome sequences of the isolates were generated using the NovaSeq sequencing platform (Illumina, USA). The unprocessed files were transmitted to Galaxy Europe for examination. Additionally, the tools Kleborate 0.3.0, MLST 2.23.0, Ortho Venn tool, Comprehensive AMR Database 3.2.8, and the Centre for Genomic Epidemiology were used for the detailed analysis. The genetic analysis revealed a large number of antibiotic resistance genes. In both isolates, mutations in the gyrA and parC genes were identified, with gyrA harbouring an S83I change and parC harbouring an S80I change, conferring resistance to fluoroquinolones. Both isolates harboured mutations in the ArnT gene, which may be responsible for phenotypic resistance to colistin. The isolates also harboured critical plasmids encoding numerous drug resistance genes. It has been shown that, following exposure, clinical strains of K. pneumoniae rapidly acquire resistance to colistin through distinct evolutionary routes, not involving mcr genes. A mutation in ArnT results in the addition of phosphoethanolamine to lipid A, thereby reducing the binding affinity of colistin. These findings significantly enhance our understanding of colistin resistance and provide crucial insights for identifying novel therapeutic targets.
Indexed as
Identifiers
42458139What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.